Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide 1”

Showing 20 of 0 results

Very early researchWithdrawnNCT04355832
What this trial is testing

Glucagon-like Peptide-1 in Type 1 Diabetes

Who this might be right for
Type1 Diabetes Mellitus
University of Maryland, Baltimore
Not applicableStudy completedNCT02792400
What this trial is testing

The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 24
Large-scale testing (Phase 3)Study completedNCT00566189
What this trial is testing

New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceObesity
University of Campinas, Brazil 36
Not applicableStudy completedNCT06721910
What this trial is testing

Interplay Between Interleukin-6 and Glucagon in the Regulation of Human Amino Acid and Protein Homeostasis

Who this might be right for
HealthyGlucagon ResistanceAmino Acid Change
University Hospital, Basel, Switzerland 26
Testing effectiveness (Phase 2)WithdrawnNCT01828125
What this trial is testing

Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal
Testing effectiveness (Phase 2)Study completedNCT02838589
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

Who this might be right for
Stroke
Christina Kruuse 30
Not applicableStudy completedNCT06895408
What this trial is testing

Separate and Combined Extrapancreatic Effects of GIP and GLP-1

Who this might be right for
Pancreatectomy; Hyperglycemia
University Hospital, Gentofte, Copenhagen 12
Early research (Phase 1)Study completedNCT07455825
What this trial is testing

Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Who this might be right for
Healthy Participants
AstraZeneca 65
Early research (Phase 1)Study completedNCT04347252
What this trial is testing

Glucagon Regulation of Glucose Metabolism

Who this might be right for
Insulin Secretion
David D'Alessio, M.D. 19
Early research (Phase 1)Ended earlyNCT04253223
What this trial is testing

Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib

Who this might be right for
Hyperglycemia Drug Induced
Duke University 1
Not applicableStudy completedNCT02497859
What this trial is testing

Breakfast Intake and Satiety Hormones

Who this might be right for
Obesity
Texas Tech University 20
Testing effectiveness (Phase 2)Study completedNCT04432090
What this trial is testing

GPR119 Agonist for Hypoglycemia in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
AdventHealth Translational Research Institute 110
Large-scale testing (Phase 3)Study completedNCT01994746
What this trial is testing

Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 77
Post-approval studies (Phase 4)UnknownNCT02344186
What this trial is testing

Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Temple University 12
Testing effectiveness (Phase 2)Study completedNCT05111912
What this trial is testing

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Who this might be right for
Obesity
Sciwind Biosciences APAC CO Pty. Ltd. 206
Testing effectiveness (Phase 2)Ended earlyNCT00798590
What this trial is testing

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Who this might be right for
Critically IllHypoglycemia
Johns Hopkins University 19
Not applicableStudy completedNCT00881543
What this trial is testing

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Who this might be right for
Diabetes Type 2
University of Sao Paulo General Hospital 45
Early research (Phase 1)Study completedNCT02550548
What this trial is testing

Incretin Action in Physiology and Diabetes

Who this might be right for
Insulin Secretion
David D'Alessio, M.D. 39
Testing effectiveness (Phase 2)Study completedNCT02282254
What this trial is testing

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT07458269
What this trial is testing

Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

Who this might be right for
Obesity
Kailera 264
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation